Guerbet develops microcatheter to address embolization risk
Guerbet has introduced a new microcatheter technology designed to mitigate the risk of non-target embolization during interventional procedures.
Guerbet is introducing a novel microcatheter technology aimed at addressing a common challenge in interventional radiology: non-target embolization. This complication, where embolic material inadvertently enters unintended vessels, can lead to serious adverse events.
The new device features a microcatheter with side-holes. Unlike traditional catheters, fluids exit from these side-holes, while the embolic material remains contained. This action reportedly creates a vortex that acts as a barrier, preventing reflux and reducing the likelihood of material reaching non-target areas.
This advancement was discussed at the Embolotherapy conference (ET) in Valencia, Spain. Interventional radiologists highlighted that non-target embolization is a frequently encountered, sometimes under-diagnosed issue. Managing this risk involves understanding vascular anatomy, precise catheter placement, and appropriate embolic agent selection.
The microcatheter received CE marking in April. Guerbet indicates this development offers a new tool to assist physicians in complex procedures. Product availability may differ by country.